Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method EquipmentLLOQ
(ng/mL)
ULOQ
(ng/mL)
1 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 8000
2 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000
3 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.10 50.0
4 Sorafenib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 20.0 8000
5 VIN-NCE-58PL NCE Human Plasma K2EDTA LC/MS/MS LCMS-8060 1.00 10000
Recently Validated Methods
Page 1 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
1Acitretin +
13 - Cis AcitretinPsoriasis Human Plasma Na Heparin LC/MS/MS API 4000 2.00 500
2Aspirin +
Salicylic acid (Sensitive)Analgesic Human Plasma K3EDTA LC/MS/MS API 4000
2.00
150
1200
10000
3
Atorvastatin +
2 - Hydroxy Atorvastatin+
4 - Hydroxy Atorvastatin+
Glimpride+
Glimpride M1 Metabolite
Antihyperlipidemic
Antidiabetic
Human Plasma K3EDTA LC/MS/MS API 4000
0.10
0.10
0.05
0.50
0.50
40
40
20
200
200
4 5-Azacitidine Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 2500
5
Bupropion +
Hydroxy Bupropion+
Erythro Bupropion +
Threo Bupropion
Antidepressant and Smoking
cessationHuman Plasma Sodium Heparin LC/MS/MS Premier XE
3.00
10.0
3.00
5.00
900
3000
900
1500
6
Bupropion +
Hydroxy Bupropion +
Erythro Bupropion +
Threo Bupropion
Antidepressant Human Plasma Na Heparin LC/MS/MS Premier XE
1.00
3.00
0.80
2.50
300
900
240
750
7 Disulfiram For Chronic Alcoholism Human Plasma Na Heparin LC/MS/MS API 3000 25.0 5000
8 Doxorubicin Metabolite (Doxorubicinol) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.25 20
9 Doxorubicin(Free) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 50.0 5000
10 Doxorubicin(Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 250 50000
11 Doxorubicin (Total) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 250 50000
Premium Methods (Generics)
Page 2 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
12 Doxorubicin (Free) Anticancer Human Plasma K3EDTA LC/MS/MS API 5500 10.0 5000
13 Doxorubicin (Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS API 5500 150 60000
14 Ergocalciferol Vitamin D2 Human Plasma K3EDTA LC/MS/MS API 5500 0.10 100
15
Estrone Unconjugated +
Estradiol Unconjugated +
Norethindrone
Oestrogen
Oestrogen
Progestogen
Human Plasma K3EDTA LC/MS/MS API 5500
0.003
0.001
0.100
0.400
0.133
13.3
16Ethinyl Estradiol(Sensitive) +
Levonorgestrel
Oestrogen
ProgestogenHuman Plasma Na Heparin LC/MS/MS API 5500
0.001
0.100
0.250
25.0
17Equilin Total +
∆8,9-dehydroestrone TotalOestrogen Human Plasma K3EDTA LC/MS/MS API 5500
0.050
0.025
8.00
4.00
18 Estrone Total Oestrogen Human Plasma K3EDTA LC/MS/MS API 5500 0.050 15.0
19
Estrone Uncojugated +
Equilin Unconjugated +
∆
Oestrogen Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.0030
0.0045
0.0045
0.400
0.600
0.600
20Fesoterodine +
5-OH Methyl Tolterodine Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 4000
0.01
0.02
7.5
15.0
21Fingolimod +
Fingolimod PhosphateMultiple sclerosis Human Blood K2EDTA LC/MS/MS API5500 0.04 0.04
5.00
5.00
22Fingolimod +
Fingolimod phosphateMultiple sclerosis Human Blood K2EDTA LC/MS/MS API 5500
0.010
0.010
5.00
5.00
23(+)-3R 5S Fluvastatin +
(-)-3S 5R FluvastatinAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.60
0.60
300
300
Premium Methods (Generics)
Page 3 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
24 Fluticasone Propionate Corticosteroid Human Plasma K2EDTA LC/MS/MS LCMS-8060 0.80 pg/mL 500 pg/mL
25 Formoterol Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.0004 0.20
2613-cis-Retinoic Acid+
4-Keto 13-cis-Retinoic AcidVitamin A Human Plasma K3EDTA LC/MS/MS Premier XE
5.00
10.0
1000
2000
27 2-Hydroxy Oleic AcidSynthetic derivative of Oleic
AcidHuman Plasma Na-Heparin LC/MS/MS API 4000 25.0 25000
28R-Ibuprofen+
S-IbuprofenNSAID Human Plasma K3EDTA LC/MS/MS API 4000 1000 32000
29R-Ibuprofen +
S-IbuprofenNSAID Human Plasma K3EDTA LC/MS/MS Premier XE
200
200
70000
70000
30
Isoniazide +
Rifampicin +
25 -Desacetyl Rifampicin+
Ethambutol +
Pyrazinamide
Antitubercular Human Plasma Na Heparin LC/MS/MS API 4000
60
15
25
15
200
6000
1500
2500
1500
20000
31 Lurasidone Metabolite 14283 Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 1000
32
Metformin+
Pioglitazone+
Hydroxy Pioglitazone
Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 10.00 2400
33R-Metoprolol+
S-Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 2.00 500
34S-Methyl N, N- Diethyl dithiocarbamate
(Disulfiram Secondary Metabolite )
For Chronic Alcoholism
(Disulfiram)Human Plasma Na Heparin LC/MS/MS API 3000 5.00 1000
35RSSS -Nebivolol +
SRRR-NebivololAntihypertensive Human Plasma K3EDTA LC/MS/MS API 5500
0.020
0.020
6.00
6.00
Premium Methods (Generics)
Page 4 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
36Niacin +
Nicotinuric Acid(Metabolite)Vitamin Human Plasma K3EDTA LC/MS/MS API 4000
5.00
15.0
1000
3000
37 Paclitaxel (Free, Unbound) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 1.00 1500
38 Paclitaxel (Free) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000
39 Penicillamine Chelating Agent Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 4000
40 PhenindioneAnticoagulant/Vitamin K
antagonistHuman Plasma K3EDTA LC/MS/MS API 4000 50.0 20000
41 Prednisolone Corticosteroid Human Plasma K3EDTA LC/MS/MS API 3000 2.00 1000
42 cis & trans-Phytonadione Vitamin K Human Plasma K3EDTA LC/MS/MS API40000.100
0.100
150
150
43R-Praziquantel +
S-PraziquantelAnthelmintic Human Plasma K3EDTA LC/MS/MS API 4000
2.00
2.00
2000
2000
44R-(+) -trans -tranylcypromine +
S-(-) -trans-tranylcypromineAntidepressant and Anxiolytic Human Plasma K3EDTA LC/MS/MS API 4000
0.100
0.200
40.0
80.0
45Trientine +
N1 -Acetyl triethylenetetramine Chelating agent Human Plasma K3EDTA LC/MS/MS API 3000
6.00
10.0
1500
2500
46
Trientine +
N1 -Acetyl triethylenetetramine +
N1,N10 -Diacetyl triethylenetetramine
Chelating agent plasma K3EDTA LC/MS/MS API3000
10.0
10.0
3.00
2000
2000
600
47
Nitroglycerin +
1, 2-Dinitroglycerin +
1, 3-Dinitroglycerin
Vasodilator Human Plasma K3EDTA LC/MS/MS API 5500
0.020
0.050
0.050
2.00
5.00
5.00
48Propranolol Total +
4-OH Propranolol Total
Beta–adrenoceptor Blocking
AgentHuman Plasma K3EDTA LC/MS/MS Premier XE 2.00 500
Premium Methods (Generics)
Page 5 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
49 Pyridostigmine Anticholinesterase Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150
50 Rivastigmine(Sensitive)Alzheimer's & Parkinson's
DiseaseHuman Plasma K3EDTA LC/MS/MS Premier XE 0.05 20.0
Premium Methods (Generics)
Page 6 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Activity/Marker Purpose Matrix
Anti-
Coagulant Method Equipment LLOQ ULOQ
1 Nitrate
Marker For the Activity of Nitric
oxide synthase and the
production of Nitric oxide
radicals
Human Plasma K3EDTA ColourimetricMicroplate
Reader5 µM 35 µM
2 Nitrite
Marker For the Activity of Nitric
oxide synthase and the
production of Nitric oxide
radicals
Human Plasma K3EDTA ColourimetricMicroplate
Reader5 µM 35 µM
3 Anti Xa
LMWH therapy is monitored by
the ratio of anti-factor Xa and
Anti Factor IIa assay, The
amount of residual factor Xa or
Factor IIa is inversely
proportional to the amount of
heparin/LMWH in the plasma
Human Plasma Na-Citrate ChromogenicMicroplate
Reader0.1 IU/mL 1 IU/mL
4 Anti IIa
LMWH therapy is monitored by
the ratio of anti-factor Xa and
Anti Factor IIa assay, The
amount of residual factor Xa or
Factor IIa is inversely
proportional to the amount of
heparin/LMWH in the plasma
Human Plasma Na-Citrate ChromogenicMicroplate
Reader0.05 IU/mL 0.2 IU/mL
5 TFPI
Extrinsic Pathway- Tissue
Factor Pathway Inhibitor, For
Determination of heparin
Presence.
Human Plasma CTAD ELISA- ColorimetricMicroplate
Reader31.25 pg/mL 2.0 ng/mL
6 C-Peptide NA Human Serum NA ELISAMicroplate
Reader28.89 pM 1850 pM
7 G-CSF Febrile Neutropenia Human Serum NA ELISA
Microplate
Reader
SYNERGY H1
2.014 50.0
Pharmacodynamic / Pharmacokinetic / Immunogenicity Determination (Validated Kit Method)
Page 7 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Activity/Marker Purpose Matrix
Anti-
Coagulant Method Equipment LLOQ ULOQ
8 Heparin Clotting AssayTo determine the clotting time
difference in presence of LMWHHuman Plasma CTAD Clotting Assay
Coagulation
Analyzer0.15 IU/mL 1.0 IU/mL
9 IgG
Immunoglobulin- IgG, specific
Heparin antibody qualitative
detection for immunogenicity of
LMWH
Human Serum NAQualitative-ELISA
Method
Microplate
ReaderNA NA
10 IgA
Immunoglobulin- IgA, specific
Heparin antibody qualitative
detection for immunogenicity of
LMWH
Human Serum NAQualitative-ELISA
Method
Microplate
ReaderNA NA
11 IgM
Immunoglobulin- IgM, specific
Heparin antibody qualitative
detection for immunogenicity of
LMWH
Human Serum NAQualitative-ELISA
Method
Microplate
ReaderNA NA
12 IgGAM
Immunoglobulin- IgG, IgM and
IgA, specific Heparin antibodies
qualitative detection for
immunogenicity of LMWH
Human Serum NAQualitative-ELISA
Method
Microplate
ReaderNA NA
13 Insulin Aspart Antidiabetic Human Serum NA ELISA
Microplate
Reader
SYNERGY H1
15.714 pM 500 pM
14 A-H-PF4 Anti Heparin Platlate factor Human Plasma CTAD ELISA- ColorimetricMicroplate
ReaderNA NA
15 Total IronFor Estimation of total Iron
after Iron sucrose therepyHuman Serum NA Colourimetric
Microplate
Reader500 ng/mL 60000 ng/mL
16 Transferrin bound Iron(TBI)
For Estimation of transferrin
bound Iron after Iron sucrose
therapy
Human Serum NA ColorimetricMicroplate
Reader200 ng/mL 8000 ng/mL
Pharmacodynamic / Pharmacokinetic / Immunogenicity Determination (Validated Kit Method)
Page 8 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. In-House ID Matrix Anti-Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
1 VIN-NCE-001 PL-1 Human Plasma Na Heparin LC/MS/MS API 4000 0.5 500
2 VIN-NCE-001 UR-1 Human Urine NA LC/MS/MS API 4000 5.0 5000
3 VIN-NCE-002 PL Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000
4 VIN-NCE-003 PL Human Plasma Na Heparin LC/MS/MS API 4000 20.0 5000
5 VIN-NCE-004 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.020 10.0
6 VIN-NCE-005 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.50 100
7 VIN-NCE-006 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 1000
8 VIN-NCE-007 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000
9 VIN-NCE-008 PL Human Plasma K2 EDTA LC/MS/MS API 4000 0.10 100
10 VIN-NCE-008 UR Human Urine NA LC/MS/MS API 4000 1.00 1000
11 VIN-NCE-009 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.10 100
12 VIN-NCE-009 UR Human Urine NA LC/MS/MS API 4000 1.00 1000
13 VIN-NCE-010 PL Human Plasma K3 EDTA LC/MS/MS API 3000 5.00 5000
Validated Methods for New Chemical Entities
Page 9 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. In-House ID Matrix Anti-Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
14 VIN-NCE-011 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000
15 VIN-NCE-012 PL Human Plasma Na Heparin LC/MS/MS API 3000 0.50 500
16 VIN-NCE-014 PL Human Plasma Na Heparin LC/MS/MS Premier XE 25.0 1000
17 VIN-NCE-013 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 500
18 VIN-NCE-015 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 500
19 VIN-NCE-016 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.10 100
20 VIN-NCE-017 BL Human Blood Na Heparin LC/MS/MS Premier XE 0.50 100
21 VIN-NCE-018 BL Human Blood Na Heparin LC/MS/MS API 3000 3.0 1200
22 VIN-NCE-019 PL Human Plasma EDTA LC/MS/MS API 2000 10.0 250
23 VIN-NCE-020 PL Human Plasma Na Heparin LC/MS/MS API 2000 1.00 25.0
24 VIN-NCE-021 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.030 100
25 VIN-NCE-022 SK Human Skin Na Heparin LC/MS/MS API 3000 12.0 9000
26 VIN-NCE-023 PL Human Plasma Na Heparin LC/MS/MS API 3000 3.00 2400
Validated Methods for New Chemical Entities
Page 10 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. In-House ID Matrix Anti-Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
27 VIN-NCE-024 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 1000
28 VIN-NCE-025 UR Human Urine Na Heparin LC/MS/MS Premier XE 0.50 1000
29 VIN-NCE-026 PL Human Blood EDTA LC/MS/MS API 3000 0.30 200
30 VIN-NCE-027 PL Human Plasma EDTA LC/MS/MS API 4000 2.00 1000
31 VIN-NCE-028 PL Human Plasma EDTA LC/MS/MS Premier XE 5.00 3000
32 VIN-NCE-029 PL Human Plasma Na Heparin LC/MS/MS Premier XE 2.00 2500
33 VIN-NCE-030 TI Colon tissue NA LC/MS/MS API 3000 12.0 9000
34 VIN-NCE-022 CT Colon tissue NA LC/MS/MS API 3000 12.0 9000
35 VIN-NCE-031 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.50 5000
36 VIN-NCE-032 PL Human Plasma K2EDTA LC/MS/MS API 5500 0.050 50.0
37 VIN-NCE-034 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.005 5.50
38 VIN-NCE-038 UR Human Urine NA LC/MS/MS API 3200 1.00 1000
39 VIN-NCE-037 UR Human Urine NA LC/MS/MS API 3200 10.0 10000
Validated Methods for New Chemical Entities
Page 11 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. In-House ID Matrix Anti-Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
41 VIN-NCE-035 PL Human Plasma K2EDTA LC/MS/MS API 3200 5.00 5000
42 VIN-NCE-041 PL Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 2000
43 VIN-NCE-039PL Human Plasma K2EDTA LC/MS/MS LCMS-8060 1.00 1000
40 VIN-NCE-043 PL Human Plasma K2EDTA LC/MS/MS API 4000 2.00 1000
44 VIN-NCE-037UR Human Urine NA LC/MS/MS API 3200 10.0 10000
45 VIN-NCE-042PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.020 10.0
46 VIN-NCE-044PL (Drug + Metabolite) Human Plasma K3EDTA LC/MS/MS Premier XE1.00
1.00
1000
1000
47 VIN-NCE-040PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 1.00 1000
48 VIN-NCE-045PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.50 2000
49 VIN-NCE-046PL (Drug + Metabolite) Human Plasma K3EDTA LC/MS/MS API 40005.00
1.00
5000
1000
50 VIN-NCE-047UR Humna Urine NA LC/MS/MS API 4000 1.00 2000
51 VIN-NCE-048PL Human Plasma K3EDTA LC/MS/MS API 3200 1.00 5000
Validated Methods for New Chemical Entities
Page 12 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. In-House ID Matrix Anti-Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
52 VIN-NCE-049PL (Drug + Metabolite) NCE Human Plasma K3EDTA LC/MS/MS0.005
0.20
5.00
20.0
53 VIN-NCE-050PL NCE Human Plasma K2EDTA LC/MS/MS 1.0 5000
54 VIN-NCE-51PL NCE Human Plasma K2EDTA LC/MS/MS0.50
0.50
1000
1000
55 VIN-NCE-52PL NCE Human Plasma K2EDTA LC/MS/MS 0.020 50.0
56 VIN-NCE-53UR NCE Human Urine NA LC/MS/MS 10.0 50.0
57 VIN-NCE-54PL NCE Human Plasma K2EDTA LC/MS/MS 50.0 20000
58 VIN-NCE-55PL NCE Human Plasma K3EDTA HPLC-UV 300µg/mL 5000µg/mL
59 VIN-NCE-56PL NCE Human Plasma K3EDTA LC/MS/MS 0.020 20.0
60 VIN-NCE-57PL NCE Human Plasma K3EDTA LC/MS/MS 1.00 1000
Validated Methods for New Chemical Entities
Page 13 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method
LLOQ
(ng/mL)
ULOQ
(ng/mL)
1
Amlodipine +
Chlorthalidone +
Telmisartan
Antihypertensive Human Plasma K3EDTA LC/MS/MS
0.10
1.00
2.00
25.0
250
500
2 Candesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS 2.00 700
3Dextromethorphan +
DextrorphanCough Suppressant Human Plasma K3EDTA LC/MS/MS
0.030
0.030
15.0
15.0
4 Doxorubicin (Free) Anticancer Human Plasma K3EDTA LC/MS/MS 10.0 5000
5 Doxorubicin (Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS 150 60000
6 Droxidopa Parkinson's disease Human Plasma K3EDTA LC/MS/MS 10.0 4000
7 Erlotinib Anticancer Human Plasma K3EDTA LC/MS/MS 10.0 2500
8 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS 5.00 2500
9 Insulin Human Antidiabetic Human Plasma K2EDTA LC/MS/MS 0.050 pg/mL 10 pg/mL
10 Iron Iron Defficiency Anaemia Human Plasma K3EDTA ICP OES 400 20000
11Lamivudine +
Tenofovir Alafenamide Antiviral Human Plasma K3EDTA LC/MS/MS
20.0
2.00
5000
500
12 Levofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS 80.0 20000
13 Levosalbutamol Ashtma Human Plasma K3EDTA LC/MS/MS 0.005 1.00
14 Magnesium Hypomagnesaemia Human Serum NA ICP OES 2000 150000
15 Methyl Prednisolone Glucocorticoid Human Plasma K3EDTA LC/MS/MS 2.00 1000
Methods Under Development / Validation
Page 14 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method
LLOQ
(ng/mL)
ULOQ
(ng/mL)
16 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS 2.00 1000
17 Omeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS 5.00 5000
18 Ospemifene Dyspareunia Human Serum NA LC/MS/MS 5.00 2000
19Oxybutynin +
Metabolite- N-Desethyl OxybutyninAnticholinergic Human Plasma K3EDTA LC/MS/MS
0.050
0.20
20.0
2000
20 Progesterone Progestogen Human Plasma K3EDTA LC/MS/MS 0.025 50.0
21 Rabeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS 4.00 2000
22 Tizoxanide Antiparasitic Human Plasma K3EDTA LC/MS/MS 50.0 25000
23 Varenicline Nicotine Addiction Human Plasma K3EDTA LC/MS/MS 5.00 1000
Methods Under Development / Validation
Page 15 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
1 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 30.0 7500
2 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.00 9000
3Abacavir +
LamivudineAntiviral Human Plasma K3EDTA LC/MS/MS API 3000
24.0
60.0
6000
15000
4 Abiraterone Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 200
5 Acetaminophen Analgesic Human Plasma Na Heparin LC/MS/MS API 3000 300.00 20000
6 Acetazolamide Carbonic anhydrase inhibitor,
diureticHuman Plasma K3EDTA LC/MS/MS API 2000 20.00 20000
7 Acetazolamide (Sensitive)Carbonic anhydrase inhibitor,
diureticHuman Plasma EDTA LC/MS/MS API 2000 10.00 5000
8 AcetazolamideCarbonic anhydrase inhibitor,
diureticHuman Plasma K3EDTA LC/MS/MS API 2000 30.00 18000
9 Acitretin Psoriasis Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.20 300
10Acitretin+
13 - Cis AcitretinPsoriasis Human Plasma K3EDTA LC/MS/MS API 4000 5.00 500
11 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 10.0
12 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 50.0
13 Alfuzosin Benign prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS API 4000 0.050 30.0
Validated Method List (Generics)
Page 16 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
14 Alfuzosin Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.40 80
15 Aliskiren Renin inhibitor Human Plasma K3EDTA LC/MS/MS API 3000 0.30 300
16 Alosetron 5-HT3 Antagonist Human Plasma K3EDTA LC/MS/MS API 4000 0.05 20
17 Alprazolam Anxiolytic Human Plasma Na Heparin LC/MS/MS Premier XE 0.20 40
18 Allopurinol Anti gout Human Plasma K3EDTA LC/MS/MS LCMS-8050 15.0 9000
19Alverine + 4-
Hydroxy Alverine Smooth muscle relaxant Human Plasma K3EDTA LC/MS/MS LCMS-8040
0.01
0.05
3.00
15.0
20 Aminocaproic acid Bleeding Disorders Human Plasma K3EDTA LC/MS/MS API 3200 500 100000
21Amlodipine +
ValsartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
0.100
100
10.0
10000
22Albendazole +
Albendazole SulfoxideAnthelmintic Human Plasma K3EDTA LC/MS/MS API 4000
0.20
4.00
100
2000
23 Amantadine Antiviral and an
Antiparkinsonian drugHuman Plasma K3EDTA LC/MS/MS API 2000 2.00 1000
24Ambroxol +
GauifenesinExpectorant Human Plasma K3EDTA LC/MS/MS API 4000
0.40
5.00
200
2500
25Amitriptyline+
NortriptylineAntidepressant Human Plasma K2EDTA LC/MS/MS Premier XE
0.20
0.08
120
48.0
26Amitriptyline+
NortriptylineAntidepressant Human Plasma K2EDTA LC/MS/MS Premier XE
0.20
0.09
120
48.1
Page 17 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
27Amitriptyline+
NortriptylineAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.20
0.050
80.0
20.0
28 Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 10.0
29
Amlodipine +
HCTZ +
Olmesartan
Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
0.05
1.00
10.0
15.0
300
3000
30Amlodipine +
OlmesartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
0.040
10.0
12.0
3000
31Amlodipine +
TelmisartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
0.05
5.00
10.0
1000
32Amlodipine +
ValsartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
0.10
40.0
12.0
4800
33 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 160 30000
34 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 200 30000
35 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 50.0 25000
36 Anastrazole Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 0.20 60
37 Apixaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
38 Apremilast Psoriatic Arthritis Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 800
39 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 4000
Page 18 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
40 Aripriprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 400
41 Aripiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 200
42 Aripiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800
43Aripriprazole +
EscitalopramAntipsychotic, Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.25
0.10
65.0
24.0
44 Armodafinil Wakefulness promoting agent Human Plasma K3EDTA LC/MS/MS API 3000 50 15000
45Artemether+
DihydroartimisninAntimalarial Human Plasma Na Heparin LC/MS/MS API 4000 3.00 360
46Artesunate +
Dihydroartemisinin Antimalarial Human Plasma K3EDTA LC/MS/MS LCMS-8040
0.800
0.800
500
500
47 Asenapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.10 20
48Aspirin +
Salicylic AcidAnalgesic Human Plasma Na Heparin LC/MS/MS API 2000 2000.00 80000
49Aspirin +
Metabolite Salicylic acidAnalgesic Human Plasma K3EDTA LC/MS/MS API 4000
4.0
100
2000
7000
50 Aspirin(Sensitive) Analgesic Human Plasma K3EDTA LC/MS/MS Premier XE 10.00 2000
51 Atenolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 8.00 2200
52 Atenolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 10.0 1500
Page 19 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
53 Atomoxetine Hyperactivity disorder (ADHD) Human Plasma EDTA LC/MS/MS API 4000 5.00 2000
54 Atorvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 200
55 Atorvastatin Antihyperlipidemic Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.50 300
56
Atorvastatin +
2 - Hydroxy Atorvastatin+
4 - Hydroxy Atorvastatin
Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 3000
0.25
0.50
0.50
50
100
100
57
Atorvastatin +
2 - Hydroxy Atorvastatin+
4 - Hydroxy Atorvastatin
Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000
0.10
0.10
0.05
100
100
50
58
Atorvastatin+
2 - Hydroxy Atorvastatin+
4 - Hydroxy Atorvastatin
Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000
0.2
0.2
0.1
200
200
100
59
Atorvastatin +
2 - Hydroxy Atorvastatin+
4 - Hydroxy Atorvastatin+
Glimpride
Antihyperlipidemic
Antidiabetic
Human Plasma K3EDTA LC/MS/MS API 4000
0.1
0.1
0.05
0.50
40
40
20
200
60 Atovaquone Antiprotozoal Human Plasma K3EDTA LC/MS/MS API 3000 100.00 20000
61 Axitinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.200 100
62 Axitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.075 100
63 Azithromycin Antibiotics Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
Page 20 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
64 Azithromycin Antibiotic Human Plasma K3EDTA LC/MS/MS API3000 5.00 2000
65 Baclofen Muscle relaxant and antispastic Human Plasma K3EDTA LC/MS/MS API 4000 5.00 1000
66 Barnidipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 0.02 10
67Benazepril +
BenazeprilatAntihypertensive Human Plasma K3EDTA LC/MS/MS API 5500
1.00
2.00
400
800
68 Bendroflumethiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200
69 Bexarotene Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
70 Bisoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100
71 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 4.50
72 Bortezomib Anticancer Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1400
73 Bortezomib Anticancer Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0
74 Bortezomib Anticancer Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0
75 Bosentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 50.00 5000
76 Bosentan(Sensitive ) Endothelin receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 20.00 5000
Page 21 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
77 Brexpiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 60.0
78 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.015 4.50
79 Bumetanide Diuretic Human Plasma K3EDTA LC/MS/MS API 3200 1.00 200
80Bupropion +
Hydroxy BupropionAntidepressant Human Plasma K3EDTA LC/MS/MS API 3000 1.50 300
81 Buspiron Anxiolytic Human Plasma K3EDTA LC/MS/MS API 3000 0.05 5.00
82 Cabergoline Dopamine receptor agonist Human Plasma K3EDTA LC/MS/MS API 5500 0.0015 0.100
83 Canagliflozin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 6000
84Canagliflozin +
Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000
5.00
5.00
3000
3000
85 Candesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 500
86Candesartan +
Hydrochlorothiazide
Antihypertensive
DiureticHuman Plasma K3EDTA LC/MS/MS API 3000
2.0
1.0
1000
500
87 Capecitabine Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.00 10000
88 Captopril Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 1000
89 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 2000 20.00 5000
Page 22 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
90 Carbamazepine Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 20.00 10000
91 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 3200 10.0 3000
92Carbidopa+
LevodopaParkinson's disease Human Plasma K3EDTA LC/MS/MS Premier XE
2.00
20.0
400
4000
93Carbidopa +
LevodopaParkinson's disease Human Plasma K3EDTA LC/MS/MS API 5500
0.25
20.0
150
4000
94Carvedilo +
4-Hydroxyphenyl CarvedilolBeta–blocker Human Plasma K3EDTA LC/MS/MS Premier XE
0.5
0.150
100
30.0
95 Carglumic AcidCarbamoyl Phosphate
Synthetase 1 activatorHuman Plasma K3EDTA LC/MS/MS API 4000 50.0 10000
96 Cefaclor Antibacterial Human Plasma CPDA, EDTA HPLC HPLC-UV 500 50000
97 Cefaclor Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 20000
98 Cefadroxil Antibiotic Human Plasma CPDA, EDTA LC/MS/MS API 2000 300 60000
99 Cefadroxil Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 40000
100 Cefditoren Antibiotic Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 5000
101 Cefixime Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 100 20000
102 Cefixime Cephalosporin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 25.00 15000
Page 23 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
103 Cefixime Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 20000
104 Cefpodoxime acid Antibacterial Human Plasma EDTA LC/MS/MS API 2000 20.0 3000
105 Cefpodoxime acid Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 200 10000
106 Cefuroxime acid Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 150 30000
107 Cefuroxime acid Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 75.0 1500
108 CelecoxibSulfa non-steroidal anti-
inflammatory drug (NSAID)Human Plasma K3EDTA LC/MS/MS API 4000 20.0 5000
109 Cephalexin Antibacterial Human Plasma EDTA HPLC HPLC-UV 200 120000
110 Cephalexin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 500 50000
111 Cephalexin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 50.0 25000
112 Cetirizine Non-sedative Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
113Chlorpheniramine +
Phenylephrine
Antihistamine
Decongestant Human Plasma K3EDTA LC/MS/MS API 4000
0.10
0.05
20.0
10.0
114 Chlorthalidone Diruretic Human Plasma K3EDTA LC/MS/MS LC 8040 20.0 8000
115 Chlorthalidone Diruretic Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000
Page 24 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
116Chlorthalidone +
TelmisartanAntihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050
1.00
2.00
250
500
117 Cinnargine Antihistamine Human Plasma EDTA LC/MS/MS Premier XE 5.00 750
118 Ciprofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 10000
119 Clarithromycin Antibacterial Human Plasma EDTA LC/MS/MS API 3000 50.0 10000
120Clarithromycin +
14(R)-hydroxy-Clarithromycin Antibacterial Human Plasma EDTA LC/MS/MS API 3000
40.0
15.0
8000
3000
121 Clarithromycin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000
122 Clindamycin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 10.0 8000
123Clobazam +
N-Desmethyl ClobazamAED Human Plasma K3EDTA LC/MS/MS Premier XE
5.00
1.00
1500
300
124Clomipramine +
Desmethyl ClomipramineAntidepressant Human Plasma K3EDTA LC/MS/MS API 3000
1.00
1.00
300
300
125Clomipramine +
Desmethyl ClomipramineAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.20
0.80
50.0
200
126Clomipramine +
DesmethylclomipramineAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.10
0.050
6.0
30.0
127 Clonazepam AED Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 30.0
128 Clonazepam AED Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.05 20.0
Page 25 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
129 Clonidine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.025 2.50
130 Clopidogrel Anti–platelet Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.20 25.0
131 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS API 4000 0.05 10.0
132 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS API 5500 0.005 5.00
133 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 10.0
134Clopidogrel+
Clopidogrel Carboxylic acidAnti–platelet Human Plasma K3EDTA LC/MS/MS API 4000
0.05
50.0
10.0
10000
135 Clozapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 1000
136 Cyclosporin (Ciclosporin) Immunosuppressant Human Blood K3EDTA LC/MS/MS Premier XE 5.00 2000
137 Dabigratan (free) Thrombin Inhibitor Human Plasma Na-Citrate LC/MS/MS API 4000 1.00 300
138 Dalfampridine Multiple sclerosis Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 100
139 Dapsone Antileprotic Human Plasma K3EDTA LC/MS/MS API 4000 25.0 5000
140Dapsone +
N-Acetyl DapsoneAntileprotic Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.045
0.015
18.0
6.00
141 S-DapoxetineSelective serotonin reuptake
inhibitorHuman Plasma EDTA LC/MS/MS API 4000 1.00 1000
Page 26 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
142 Darifenacin Urinary incontinence Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 5.00
143 Darifenacin Urinary incontinence Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 12.0
144 Darunavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 20000
145 Dasatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
146 Dasatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 1.00 400
147 Deferasirox Iron Chelator Human Plasma K3EDTA LC/MS/MS API 2000 100 60000
148Deferiprone +
Deferiprone GlucuronideIron Chelator Human Plasma Na Heparin LC/MS/MS API 2000
250
125
40000
20000
149 Desipramine Antidepressant Human Plasma K3EDTA LC/MS/MS API4000 0.50 150
150Desipramine +
2-Hydroxy DesipramineAntidepressant Human Plasma K3EDTA LC/MS/MS API 4000
0.5
0.15
150
45
151 Desloratadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0
152Desloratadine +
3-Hydroxy DesloratidineAntihistamine Human Plasma K3EDTA LC/MS/MS API 4000 0.05 10.0
153Desloratidine +
3-Hydroxy DesloratidineAntihistamine Human Plasma EDTA LC/MS/MS API 4000 0.05 10.0
154Desloratidine +
3-Hydroxy desloratidineAntihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050
25.0
25.0
7500
7500
Page 27 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
155 DesmopressinSynthetic replacement of
vasopressin harmone Human Plasma K3EDTA LC/MS/MS APi5500 0.002 0.025
156 Desvenlafaxine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 700
157 Dexlansoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2500
158Dextromethorphan +
DextrorphanCough Suppressant Human Plasma K3EDTA LC/MS/MS API 3000
0.10
10.0
20.0
2000
159Dextromethorphan +
Guanafenesin
Cough Suppressant
ExpectorantHuman Plasma K3EDTA LC/MS/MS API 3000
0.10
25.0
20.0
5000
160Diacerein +
Rhein Osteoarthritis Human Plasma K3EDTA LC/MS/MS LCMS-8050
15.0
15.0
6000
6000
161 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 25.0 4000
162 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8040 10.0 4000
163Diclofenac +
Esomeprazole
Analgesic
Proton pump inhibitorHuman Plasma K3EDTA LC/MS/MS API 4000
8.00
4.00
4000
2000
164 Dicloxacillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 200 80000
165 Dihydroartemisinin Anitmalerial Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
166 Dihydrotetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 200
167
Diltiazem +
N-Desmethyl Diltiazem +
Desacetyl Diltiazem
Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000
1.5
0.5
0.5
450
150
150
Page 28 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
168
Diltiazem +
N-Desmethyl diltiazem +
Desacetyl diltazem
Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040
4.00
1.00
0.50
1200
300
150
169Diphendydramine +
Naproxen
Sedative antihistamine
NSAIDHuman Plasma K3EDTA LC/MS/MS API 4000
0.50
500
150
150000
170 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 4500
171 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 5000
172 Disulfiram Metabolite 2For Chronic Alcoholism
(Disulfiram)Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 250
173 Disulfiram Primary MetaboliteNA (Inactive Metabolite of
Disulfiram)Human Plasma K3EDTA HPLC-UV Shimadzu LC20 2.00 200
174 Dofetilide Antiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000 0.010 5.00
175 Dolutegravir Antiviral Human Plasma K3EDTA LC/MS/MS API 5500 20.0 8000
176 Donepezil Nootropic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200
177Donepezil +
MemantineAlzheimer Human Plasma K3EDTA LC/MS/MS API 4000
0.50
0.50
200
200
178 Doxazosin Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 50.0
179Doxepin +
NordoxepinAntidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8040
0.20
0.050
80.0
20.0
180 Doxorubicin (Total) Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 150 60000
Page 29 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
181 Doxycycline Antibacterial Human Plasma Na Heparin LC/MS/MS Premier XE 10.0 5000
182 Doxycycline Antibacterial Human Plasma EDTA LC/MS/MS Premier XE 10.0 1500
183 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API3000 10.0 7000
184 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 10.0 7000
185Dronedarone+
Desbutyl Dronedarone (Metabolite)Antiarrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE
0.50
0.50
300
300
186 Duloxetine (Sensitive) Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.40 150
187 Duloxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100
188 Dutastaride 5-alpha-reductase inhibitor Human Plasma K3EDTA LC/MS/MS API-4000 0.10 25.0
189 Efavirenz Antiviral Human Plasma EDTA HPLC HPLC-UV 50.0 9000
190 Efavirenz Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 30.0 6000
191 Eletriptan Anti-Migraine Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 250
192 Eliglustat Gaucher's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 100
193 Eltrombopag Thrombocytopenia Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 30000
Page 30 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
194 Empagliflozin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 3.00 1200
195 Emtricitabin Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.0 3000
196Emtricitabine +
Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 3000
20.0
4.00
4000
800
197Emtricitabine +
Tenofovir AlafenamideAntiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040
20.0
2.00
5000
500
198Enalapril +
EnalaprilatAntihypertensive Human Plasma EDTA LC/MS/MS API 3000
5.00
2.00
1000
450
199Enalapril +
EnalaprilateAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
1.00
0.50
500
250
200Entacapone +
Metabolite Antiparkinsonian Human Plasma K3EDTA HPLC HPLC-UV 50.0 6000
201Entacapone +
Metabolite (Sensitive) Antiparkinsonian Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 6000
202 Entecavir Antiviral Human Plasma K3EDTA LC/MS/MS API 5500 0.040 20.0
203 EnzalutamideMetastatic castration-resistant
prostate cancer (CRPC)Human Plasma K3EDTA LC/MS/MS API 2000 10.0 10000
204 Eplerenone Chronic Heart Failure Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 4000
205 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 4000
206Eprosartan +
Hydrochlorothiazide
Antihypertensive
DiureticHuman Plasma K3EDTA LC/MS/MS API 3000
30.0
1.00
7500
500
Page 31 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
207 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 6000
208 Erlotinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 12.5 2500
209 Erlotinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 1.00 2500
210 Erythromycin Antibacterial Human Plasma EDTA LC/MS/MS API 2000 20.0 2000
211 Erythromycin Antimicrobial Human Plasma K3EDTA LC/MS/MSPremier XE /
API400010.0 4000
212 Escitalopram Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.30 200
213 Escitalopram Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 50.0
214Escitalopram +
S (+) DesmethylcitalopramAntidepressant Human Plasma K3EDTA LC/MS/MS API 4000
0.20
0.040
50.0
10.0
215 Eslicarbazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 2000 100 30000
216 Esomeprazole Proton pump inhibitor Human Plasma CPDA, EDTA LC/MS/MS API 2000 10.0 3500
217 Esomeprazole (Sensitive) Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 2000 5.00 3500
218 Esomeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 10.0 4000
219Esomeprazole +
Naproxen
Proton pump inhibitor
NSAIDHuman Plasma K3EDTA LC/MS/MS API 4000
5.0
500
1500
150000
Page 32 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
220Esomeprazole+
Naproxen
Proton pump inhibitor
NSAIDHuman Plasma K3EDTA LC/MS/MS API 4000
2.0
500
600
150000
221Ethinyl Esterdiol +
LevonorgetralOestrogen Human Plasma Sodium Heparin LC/MS/MS API 5500
0.004
0.10
0.50
20.0
222 Ethosuximide Anticonvulsant Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 20000
223 Etodolac Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 500 80000
224 Etodolac Nonsteroidal anti-inflammatory Human Plasma K3EDTA LC/MS/MS Premier XE 250 80000
225 Etoposide Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 20.0 8000
226 Etoricoxib COX-2 selective inhibitor Human Plasma K3EDTA LC/MS/MS API2000 10.0 5000
227 Everolimus Anticancer Human Blood K3EDTA LC/MS/MS API3000 0.30 200
228 Exemestane Aromatase inhibitor, Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.10 40.0
229Ezetimib +
Ezetimibe-O-beta-glucuronideAntihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050
0.10
1.00
25.0
250
230Ezetimibe +
Ezetimibe Phenoxy GlucuronideAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500
0.10
1.00
30.0
300
231 Ezetimibe(Unconjugated) Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.13 20
232 Ezetimib (Total) Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8040 1.00 200
Page 33 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
233Ezetimibe+
Ezetimibe PhenoxygluconorideAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000
0.10
1.00
15.0
150
234 Febuxostat Inhibitor of Xanthine Oxidase Human Plasma K3EDTA LC/MS/MS API 4000 50 10000
235 Felodipine Antihypertensive Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0
236 Felodipine Calcium channel blocker Human Plasma K3EDTA LC/MS/MS API 4000 0.10 10.0
237 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 25.0 10000
238 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 20000
239 Fenoprofen Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 3000 250 100000
240Fesoterodine +
5-Hydyroxy methyl tolterodineAntimuscarinic Human Plasma K3EDTA LC/MS/MS API 5500
0.001
0.02
0.750
15.0
241 Fexofenadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 2000 8.00 1000
242Fexofenadine +
PseudoephedrineAntihistamine Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1500
243Fexofenedine +
Pseudoephedrine (Sensitive)Antihistamine Human Plasma K3EDTA LC/MS/MS Premier XE
1.00
2.00
500
1000
244 Fingolimod Multiple sclerosis Human Blood K2EDTA LC/MS/MS API 5500 0.010 5.00
245 Flecainide Anti–arrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 800
Page 34 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
246 Fluconazole Antifungal Human Plasma CPDA, EDTA LC/MS/MS API 2000 50 10000
247 Flucytosine Antimycotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
248 Flucytosine Antifungal Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
249 Fluoxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 100
250Fluoxetine +
NorfluoxetineAntidepressant Human Plasma EDTA LC/MS/MS API 4000 2.00 400
251 Fluphenazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.020 5.00
252 Fulvestrant Anticancer Human Plasma K3EDTA LC/MS/MS API3000 0.10 25.0
253 Fulvestrant Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.10 25.0
254 Gabapentin Anticonvulsant Human Plasma EDTA LC/MS/MS API 2000 40.0 10000
255 Gabapentin Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 40.0 6000
256 Gefitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 250
257 Gefitinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 1.50 450
258 Glibenclamide (Glyburide) Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
Page 35 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
259Glibenclamide +
Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050
2.00
10.0
600
3000
260 Gliclazide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 5000
261 Gliclazide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 12000
262 Glimepiride Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
263 Glimpiride Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 1.00 500
264 Glimepiride Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800
265 Glipizide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2000
266 Griseofulvin Antifungal Human Plasma K3EDTA LC/MS/MS API 2000 10.0 4000
267 Granisetron Anti–emetic Human Plasma EDTA LC/MS/MS API 2000 0.15 15
268 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS API 2000 43.77 5606
269 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 6000
270 Guanfacine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.025 10.0
271 Hydralazine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 200
Page 36 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
272 Hydrochlorothiazide Diuretic Human Plasma EDTA LC/MS/MS API 2000 5.00 500
273 Hydrochlorothiazide (Sensitive) Diuretic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
274Hydrochlorothiazine +
TelmisartanAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
1.50
5.00
300
1000
275 Hydrocortisone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 4000 0.50 1000
276 Hydroxycarbamide Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 30000
277 Hydroxychloroquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 2000 2.00 600
278Hyoscine Butyl Bromide
(Butyl Scopolamine)Abdominal pain Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.25
279 Ibrutinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 100
280 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 500 100000
281 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 150 30000
282 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 250 100000
283 Idelasisib Chronic lymphocytic leukemia Human Plasma K3EDTA LC/MS/MS API 3200 10.0 4000
284 Imatinib Anticancer Human Plasma K3EDTA LC/MS/MS API2000 25.0 8000
Page 37 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
285 Imatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 25.00 6000
286Imatinib +
N-Desmethyl ImatinibAnticancer Human Plasma K3EDTA LC/MS/MS API 3200
20.0
2.00
10000
1000
287 Indapamide Antihypertensive Human Blood K3EDTA LC/MS/MS API 4000 0.20 100
288 Indomethacin Nonsteroidal anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 25.0 5000
289 Indoramin Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.04 80
290Irbesaratan +
Hydrochlorothiazide
Antihypertensive
DiureticHuman Plasma K3EDTA LC/MS/MS API 3000
10.0
1.00
5000
500
291 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 2000
292 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 1000
293 Itraconazole Antifungal Human Plasma CPDA, EDTA LC/MS/MS API 4000 2.00 600
294Itraconazole +
Hydroxy ItraconazoleAntifungal Human Plasma K3EDTA LC/MS/MS API 3000 2.00 600
295 Ivabradine Heart rate lowering agent Human Plasma K3EDTA LC/MS/MS Premier XE 0.25 100
296Ivabradine +
N-desmethyi ivabradineHeart rate lowering agent Human Plasma K3EDTA LC/MS/MS API 4000
0.20
0.050
100
25.0
297 Ivacaftor Cystic fibrosis Human Plasma K3EDTA LC/MS/MS API 3200 2.00 2000
Page 38 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
298 Ketoprofen Anti-Inflammatory, Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 10000
299 Ketorolac Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2000
300 Ketotifen NSAID Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.002 1.00
301 Lacosamide AED Human Plasma K3EDTA LC/MS/MS LCMS-8040 50.0 10000
302 Labetalol Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 1.0 500
303 Lamivudine Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 60.0 6000
304Lamivudine +
Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 3200
20.0
5.00
4000
1000
305Lamivudine +
ZidovudineAntiviral Human Plasma K3EDTA LC/MS/MS API 2000
40.0
60.0
4000
6000
306Lamivudine +
AbacavirAntiviral Human Plasma EDTA LC/MS/MS API 3000
55.0
30.0
11000
6000
307
Lamivudine +
Nevirapine +
Zidovudine
Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.0 6000
308
Lamuvudine +
Nevirapine +
Zidovudine
Antiviral Human Plasma K3EDTA LC/MS/MS API 2000
40.0
50.0
60.0
4000
5000
6000
309 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma K2EDTA LC/MS/MS Premier XE 40.0 10000
310 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma K3EDTA LC/MS/MS API 4000 5.00 4000
Page 39 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
311 Lansoprazole Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 5.00 2000
312 Lansoprazole (Sensitive) Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 2.00 2000
313 Lansoprazole Proton-pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
314 Lapatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.0 5000
315 Lenalidomide Anticancer (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000
316 Lenalidomide Anticancer (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 100
317 Lenvatinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.40 400
318 Letrozole Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 100
319 Letrozole Breast Cancer Human Plasma K3EDTA LC/MS/MS API 3200 1.00 400
320 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000
321 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000
322 LevocarnitinePrimary systemic carnitine
deficiencyHuman Plasma K3EDTA LC/MS/MS LCMS-8040 100 20000
323 Levocetirizine Non-sedative antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 10.0 600
324 Levofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 16000
Page 40 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
325 Levothyroxine Thyroid Hormone Defficiency Human Serum NA LC/MS/MS Premier XE 10.0 1000
326Lidocaine +
PrilocaineLocal Anesthetic Human Plasma K2EDTA LC/MS/MS API 4000
0.60
0.40
300
200
327 Linagliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.035 14.0
328 Linezolid Antibiotic Human Plasma K3EDTA LC/MS/MS API 3000 100 24000
329 Lisinopril Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 1.00 200
330 Lisinopril Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.50 60
331 Lithium Antidepressant Human Plasma K3EDTA ICP OES Optima 8000 50.0 5000
332 Loperamide Antidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500 0.01 4.00
333Loperamide +
N-Desmethyl LoperamideAntidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500
0.010
0.010
4.00
4.00
334Lopinavir +
RitonavirAntiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE
30.0
3.00
15000
1500
335Loratadine +
DesloratadineAntihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 50
336 Loratadine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.075 25.0
337 Lorcaserin Weight Loss Human Plasma K3EDTA LC/MS/MS API 4000 0.40 200
Page 41 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
338 LosartanAngiotensin II Receptor
AntagonistHuman Plasma K3EDTA LC/MS/MS API 3000 1.00 500
339 Lumefantrine Antimalarial Human Plasma Na Heparin LC/MS/MS Premier XE 50.0 20000
340 Lurasidone Antipsychotic Human Serum NA LC/MS/MS API4000 0.25 150
341 Lurasidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.25 150
342 Magnesium Hypomagnesaemia Human Urine NA ICP OES Optima 8000 2000 350000
343 Macitentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00 500
344 Maraviroc Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 0.50 500
345 Meclizine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 300
346 Mefenamic Acid (Sensitive) Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 40.5 12000
347 Mefenamic Acid (Sensitive) Non-steroidal Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 3000 20.0 11000
348 Mefenamic acid Non steroial anti inflammatory Human Plasma K3EDTA LC/MS/MS API2000 30.0 12000
349 Memantine Anti-Alzheimer's Human Plasma EDTA LC/MS/MS API 3000 0.50 100
350 Mercaptopurine Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 0.50 80.0
Page 42 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
351 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2000
352 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2000
353 Metaxalone Muscle Relaxant Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000
354 Metformin Antidiabetic Human Plasma EDTA HPLC HPLC-UV 40.0 7500
355 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 40.0 7500
356 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 7500
357 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 4.00 800
358Metformin +
SitagliptinAntidiabetic Human Plasma K3EDTA LC/MS/MS API 4000
10.0
2.00
4000
800
359 Methenamine Urinary Tract Infection Human Plasma K3EDTA LC/MS/MS API 3200 0.050 20.0
360 Methimazole Antithyroid Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500
361 Methotrexate antimetabolite and antifolate Human Plasma EDTA LC/MS/MS API 4000 1.00 250
362 Methoxsalen Dermatological Human Plasma EDTA LC/MS/MS API 4000 1.00 200
363 Methoxsalen (Sensitive) Dermatological Human Plasma EDTA LC/MS/MS API 4000 0.10 100
Page 43 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
364 Methyl Ergonovine Postpartum Hemorrhage Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.040 10.0
365 Methylphenidate CNS Stimulant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 100
366 Methyl Prednisolone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 3000 0.20 100
367 Metolazone Metolazone Human Plasma K3EDTA LC/MS/MS API 5500 0.15 150
368Metopimazine +
Metopimazine AcidAntiemetic Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.20
0.40
100
200
369 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.30 300
370 Metoprolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.30 300
371 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.30 300
372 Metronidazole Antiamoebic Human Plasma CPDA, EDTA HPLC HPLC-UV 100 40000
373 Metronidazole Antiamoebic Human Plasma K3EDTA LC/MS/MS Premier XE 100 40000
374 Metronidazole Antiamoebic Human Stool NA LC/MS/MS API-4000 0.50 250
375 Minocycline Antibiotic Human Plasma Na Heparin LC/MS/MS API 4000 10.0 3000
376 Minocycline Antibiotic Human Plasma K2EDTA LC/MS/MS API 4000 10.0 3000
Page 44 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
377 Mirabegron Urinary incontinence Human Plasma Na Heparin LC/MS/MS API 5500 0.100 80.0
378 Mono Methyl Fumarate Multiple Sclerosis Human Plasma K3EDTA LC/MS/MS API 3000 10.0 5000
379Montalukast+
Fexofenadin
leukotriene receptor antagonist
AntihistamineHuman Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
380 Montelukast Lukotriene receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 5.00 1000
381 Montelukast leukotriene receptor antagonist Human Plasma EDTA LC/MS/MS API 4000 5.00 1000
382 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 5000
383 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 40.0 10000
384 Mycophenolic acid Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 300 50000
385 Mycophenolic acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 40.5 20000
386 Mycophenolate Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 40.0 20000
387 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS Premier XE 200 50000
388 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 40.0 20000
389 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 60.0 30000
Page 45 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
390 Mycophenolate Mofetil Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 20.0 800
391 Mycophenolate Mofetil Immunosuppressant Human Plasma EDTA LC/MS/MS API 4000 0.10 16.0
392 Mycophenolate Mofetil Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 5500 0.01 10.0
393 Nadolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 1.00 600
394Naltrexone +
6ß Naltrexone Opioid antagonist Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.10
0.50
35.0
175
395 Naproxen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 10.0 10000
396 Naproxen Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 500 150000
397 Naratriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
398 Nateglinide Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 50.0 12000
399 Nebivolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.05 5.00
400 Nebivolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.04 15.0
401 Nifedipine Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.40 200
402 Nefopam Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 200
Page 46 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
403 Nefopam Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 200
404 Nevirapine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.00 5000
405 Nilutamide Antiandrogen Human Plasma K3EDTA LC/MS/MS API 4000 40.0 8000
406 Nilotinib Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 6.00 3000
407 NintedanibIdiopathic pulmonary fibrosis
(IPF)Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
408 Nitrofurantoin Antibiotic Human Plasma EDTA LC/MS/MS API 4000 10.0 1500
409 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 600
410 Nizatidine Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 20.0 5000
411 Norethisterone (Norethindrone) Progestogen Human Plasma K3EDTA LC/MS/MS API 5500 0.50 100
412 Norfloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000
413 Nortriptyline Antidepressant Human Plasma EDTA LC/MS/MS API 3000 0.50 220
414 Nortriptyline Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 50.0
415 Ofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000
Page 47 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
416 Olanzapine Antipsychotic Human Plasma EDTA LC/MS/MS API 3000 0.50 50.0
417 OlmesartanAngiotensin II receptor
antagonistHuman Plasma K3EDTA LC/MS/MS API 4000 10.0 3000
418Olmesartan +
Hydrochlorothiazide
Angiotensin II receptor
antagonist
Diuretic
Human Plasma K3EDTA LC/MS/MS API 400010.0
1.00
3000
300
419 Olanzepine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
420 Olanzapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3200 0.30 120
421 Olsalazine Ulcerative colitis Human Plasma K3EDTA LC/MS/MS API 4000 20.0 2000
422 Omeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2000
423 Omeprazole Proton Pump Inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 2.00 2000
424 Ondansetron Anti–emetic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 80.0
425 Orphenadrine Antihistamine Human Plasma K3EDTA LC/MS/MS API 2000 4.00 800
426Oseltamivir +
Oseltamivir CarobxylateAntiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.50
2.00
250
1000
427Oseltamivir +
Oseltamivir CarboxylateAntiviral Human Plasma K3EDTA LC/MS/MS API 3000
0.50
2.00
200
800
428 Ospemifene Dyspareunia Human Serum NA LC/MS/MS LCMS-8040 5.00 2000
Page 48 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
429 Oxaprozin Total NSAID Human Plasma K3EDTA LC/MS/MS LCMS-8040 500 160000
430
Oxcarbazepine +
10, 11-Dihydro-10-hydroxy-
Carbamazepine
Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 200020.0
75.0
4000
15000
431Oxybutynin +
Metabolite- N-Desethyl OxybutyninAnticholinergic Human Plasma K3EDTA LC/MS/MS API 4000
0.05
0.50
10.0
100
432 Paclitaxel (Total) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 5.00 15000
433 Paclitaxel (Total) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 80.0 40000
434 Palbociclib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
435 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 150
436 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 50.0
437 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.050 50.0
438 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 250
439 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 15.0 5000
440 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 10.0 6000
441 Paracetamol Antipyretic Human Plasma K3EDTA LC/MS/MS API 3000 200 20000
Page 49 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
442 Paroxetin Antidepressant Human Plasma K3EDTA LC/MS/MS API 3000 0.40 200
443 Paroxetine Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.40 60.0
444 Pazopanib Anticancer Human Plasma K2EDTA LC/MS/MS API 4000 100 40000
445 Pemetrexed Lung Cancer Human Plasma K3EDTA LC/MS/MS API 3200 500 200000
446 Perampanel Antiepileptic Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 1000
447 Phenobarbital AEDs Human Plasma K2EDTA LC/MS/MS Premier XE 10.00 4000
448 Phloroglucinol Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2500
449 Pimozide Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.02 5.00
450 Pindolol Beta Blocker Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
451Pioglitazone +
Hydroxy Pioglitazone M IV Antihyperglycemic, antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000
10.0
5.00
3000
1500
452 Piperaquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 4000 2.00 300
453 Pirfenidone Idiopathic pulmonary fibrosis
(IPF)Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 25000
454 Piroxicam NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 10000
Page 50 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
455 Pomalidomide Anticancer (Multiple Myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 150
456 Posaconazole Antifungal Human Plasma K3EDTA LC/MS/MS API3000 2.00 2000
457 Pramipexole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.00
458 Pravastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.40 200
459 Pravastatin Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.30 200
460 Praziquantel Anthelmintic Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000
461 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 15000
462 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 15000
463
Pregabalin+
Gabapentin+
Carbamazepine+
Levetiracetam
AEDs Human Plasma K2EDTA LC/MS/MS Premier XE
30.0
100
10.0
60.0
6000
20000
2000
120000
464 Primaquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 0.50 200
465 Primidone Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 50.00 40000
466Propafenone+
5-Hydroxy PropafenoneAntiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000
0.20
0.20
400
400
467 Pottasium Hypokalaemia Human Urine NA ICP OES Optima 8000 20000 3000000
Page 51 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
468 Prasugrel Metabolite R95913 Platelet Inhibitor (Prasugrel) Human Plasma K2EDTA LC/MS/MS API 4000 0.50 100
469 Prochlorperazine Tranquilliser Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.600
470 Proguanil Antimalarial Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
471 Promethazine Antihistaminic Human Plasma K3EDTA LC/MS/MS API2000 0.20 60.0
472 Propofol Sedative-hypnotic Human Plasma K3EDTA LC/MS/MS API 5500 5.00 5000
473Propafenone +
5-Hydroxy metaboliteAnti-arrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE
5.00
2.50
1000
500
474Propranolol +
4-Hydroxy Propranolol(Free)Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000
0.10
0.30
100
30.0
475 Pyrazinamide Antitubercular Human Plasma Na Heparin LC/MS/MS LCMS-8050 200 60000
476 Quetiapine Antipsychotic Human Plasma EDTA LC/MS/MS Premier XE 2.00 2000
477 Quetiapine Antipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 200
478 Quetiapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 600
479 Quinine Antimalarial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 8000
480 Rabeprazole Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 2000 3.00 2000
Page 52 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
481 Rabeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 3.00 1000
482 Raltegravir Antiretroviral Human Plasma K3EDTA LC/MS/MS API 4000 20.0 10000
483 Ramipril Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 0.20 100
484Ramipril+
RamiprilatAntihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
485 Ranitidine Antihistamine Human Plasma EDTA LC/MS/MS API 2000 5.00 1000
486 Ranitidine Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 10.0 3000
487 Ranolazine Antianginal Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 8000
488 Rasagiline Parkinsons disease plasma K3EDTA LC/MS/MS Waters 0.02 10.0
489 Repaglinide Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 0.50 200
490 Rifaximin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 0.025 10.0
491 RilpivirinNon-nucleoside Reverse
Transcriptase InhibitorHuman Plasma K3EDTA LC/MS/MS API 2000 2.00 500
492Risperidone +
9-Hydroxy RisperidoneAntipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE
0.20
0.20
100
100
493 Ritonavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 2.50 1500
Page 53 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
494 Rivoroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 800
495 Rivaroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 500
496 RivastigmineAlzheimer's&Parkinson's
DiseaseHuman Plasma K3EDTA LC/MS/MS Premier XE 0.10 50.0
497 Rizatriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 100
498 Rizatriptan Anti-Migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 60.0
499Roflumilast +
Roflumilast N-Oxide
Severe COPD associated with
chronic bronchitisHuman Plasma K3EDTA LC/MS/MS Premier XE
0.20
0.25
40.0
50.0
500 Ropinirole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.00
501 Ropinirole Antiparkinsonian Human Plasma K3EDTA LC/MS/MS API 4000 0.02 4.00
502Rosiglitazone +
MetforminAntidiabetic Human Plasma EDTA LC/MS/MS API 2000
6.00
40.0
1100
7600
503Rosiglitazone +
N-Desmethyl RosiglitazoneAntidiabetic Human Plasma K3EDTA LC/MS/MS API 2000
5.00
2.50
1000
500
504 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS Premier XE 0.60 100
505 Rosuvastatin Lowering Cholesterol Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150
506 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
Page 54 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
507 Rufinamide Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 30.0 9000
508 S-Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 12.0
509S-Amlodipine+
Hydrochlorothiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS API4000
0.03
1.00
12.0
400
510S-Amlodipine +
Hydrochlorothiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS API4000
0.03
1.00
12.0
400
511 Scopolamine Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.005 0.50
512 Secnidazole Antiamoebic Human Plasma K3EDTA LC/MS/MS API 3200 200 80000
513 Sertraline Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 1.50 300
514 Sertraline Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.20 80.0
515 SildenafilAntihypertensive, Erectile
dysfunctionHuman Plasma K3EDTA LC/MS/MS API 3000 8.00 1040
516Sildenafil +
Metabolite
Antihypertensive, Erectile
dysfunctionHuman Plasma K3EDTA LC/MS/MS API 3000 2.00 1000
517Sildenafil +
Piperazine N-desmethyl Sildenafil
Antihypertensive, Erectile
dysfunctionHuman Plasma K3EDTA LC/MS/MS API 3000
5.00
1.00
2000
400
518Sildenafil +
N-desmethyl sildenafil
Antihypertensive, Erectile
dysfunctionHuman Plasma K3EDTA LC/MS/MS API 4000
1.00
0.20
500
100
519Silodosin +
Silodsoin GlucuronideBenign prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS LCMS-8050
0.50
0.40
300
240
Page 55 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
520Simvastatin +
β - hydroxy AcidAntihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.50 100
521Simvastatin +
β - hydroxy AcidAntihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.25 32.0
522Simvastatin +
Simvastatin acidAntihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000
0.200
0.200
100
100
523Simvastatin +
Simvastatin AcidAntihyperlipidemic Human Plasma Na Heparin LC/MS/MS API 4000
0.50
0.50
200
200
524 Siimvastatin Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.040 20.0
525 Simvastatin Acid Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.02 7.50
526 Sirolimus Immunosuppressant Human Blood EDTA LC/MS/MS API 4000 0.40 40.0
527 Sirolimus (Sensitive) Immunosuppressant Human Blood K3EDTA LC/MS/MS Premier XE 0.10 50.0
528 Sitagliptin Antihyperglycemic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 800
529
Sodium Phenyl Butyrate +
Metabolite Phenyl acetate+
Metabolite Phenylacetylglutamine
For Urea cycle disorders Human Plasma K3EDTA LC/MS/MS API 2000
5 µg/mL
1 µg/mL
2 µg/mL
750 µg/mL
750µg/mL
300 µg/mL
530 Sofosbuvir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040 5.00 2000
531Sofosbuvir +
Sofosbuvir GS331007Antiviral Human Plasma K3EDTA LC/MS/MS LC 8040
5.00
10.0
1500
3000
532 Solifenacin Urinary antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 125
Page 56 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
533 Solifenacin (Sensitive) Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 4000 0.20 130
534 Sorafenib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 10000
535 Sotalol Antiarrhythmic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 3000
536 Sulfadiazine Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 250 40000
537Sulphamethoxazole +
Trimethoprim Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000
0.50
0.025
100
5.00
538 Sumatripatan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
539 Sunitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.25 100
540 Tacrolimus Immunosuppressant Human Blood EDTA LC/MS/MS Premier XE 0.50 100
541 Tacrolimus Immunosuppressant Human Blood EDTA LC/MS/MS Premier XE 0.25 75.0
542 Tacrolimus Immunosuppressant Human Blood K3EDTA LC/MS/MS LCMS-8050 0.050 75.0
543 TadalafilAntihypertensive, Erectile
dysfunctionHuman Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 800
544 Tamsulosin Prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 30.0
545 Tamsulosin α1a-selective alpha blocker Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
Page 57 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
546 Tapentadol Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 200
547 Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 3.00 1200
548 Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 5.00 1000
549 Telmisartan Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 500
550Telmisartan +
AmlodipineAntihypertensive Human Plasma K3EDTA LC/MS/MS API 4000
2.50
0.075
500
15.0
551 Temozolamide Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 100 20000
552 Temozolomide Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 20000
553 Tenofovir Antiviral Human Serum NA LC/MS/MS API 4000 5.00 1000
554 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000
555 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 50.0
Page 58 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
556
Tenofovir +
Emtricitabine +
Lamivudine
Antiviral Human Plasma EDTA LC/MS/MS API 4000
4.00
15.0
20.0
800
3000
4000
557 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000
558Tenofovir+
Emtricitabine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000
8.00
30.0
1600
6000
559
Tenofovir +
Emtricitabine +
Rilpivirine
Antiritroviral Human Plasma K3EDTA LC/MS/MS API 4000
4.00
20.0
1.00
800
4000
200
560
Tenofovir +
Emtricitabine +
Nevirapine
Antiritroviral Human Plasma K3EDTA LC/MS/MS API 4000
4.00
20.0
20.0
800
4000
4000
561 Tenofovir Alafenamide Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 1000
562Tenofovir Alafenamide +
LamivudineAntiviral Human Plasma K3EDTA LC/MS/MS API 3200
2.00
20.0
500
5000
563 Terbinafine Antifungal Human Plasma EDTA HPLC HPLC-UV 25.0 5000
564 Terbinafine Antifungal Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 3000
565 Teriflunomide Multiple sclerosis Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000
566 Tetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.01 2.00
567 Tetracycline Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 20.0 8000
Page 59 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
568 Tiagabine Anticonvulsant Human Plasma EDTA LC/MS/MS API 4000 0.50 250
569 Ticagrelor Platelet aggregation inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 2.50 1200
570 Tinidazole Antiprotozoal Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 30000
571 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
572 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.075 20.0
573 Tofacitinib Rheumatoid arthritis Human Plasma K3EDTA LC/MS/MS API 3200 0.20 100
574Tolcapone +
3-O-Methyltolcapone
Reversible inhibitor of catechol-
O-methyltransferase (COMT)Human Plasma K3EDTA LC/MS/MS API 4000
40.0
2.00
8000
400
575 Tolterodine Antimuscarinic Human Plasma EDTA LC/MS/MS API 3000 0.10 20.0
576Tolterodine +
5-Hydroxy Methyl TolterodineAntimuscarinic Human Plasma EDTA LC/MS/MS API 3000 0.03 10.0
577Tolterodine+
5-Hydroxymethyl TolterodineAntimuscarinic Human Plasma K3EDTA LC/MS/MS API 3000
0.025
0.025
10.0
10.0
578 Topiramate Anticonvulsant Human Plasma CPDA, EDTA LC/MS/MS API 4000 18.0 5000
579 Topiramate (Sensitive) Anticonvulsant Human Plasma EDTA LC/MS/MS API 4000 5.00 5000
580 Torsemide Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 20.0 6000
Page 60 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
581 Total Iron Iron Defficiency Anaemia Human Serum NA ICP OES Optima 8000 500 60000
Page 61 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
582 Tramadol hydrochloride Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 3.00 750
583 Trametinib Anticancer Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.25 250
584 Transferrin Bound Iron NA Human Serum NA ICP OES Optima 8000 200 8000
585 Transerrin Bound Iron
For Estimation of transferrin
bound Iron after Ferrmoxytol
and Ferric carboxy maltose
therapy
Dog Serum NA ICP OES Optima 8000 500 20000
586 Tranylcypromine Antidepressant and Anxiolytic Human Plasma K3EDTA LC/MS/MS API 4000 0.30 150
587 Trazodone Antidepressant Human Plasma EDTA LC/MS/MS API 4000 10.0 3000
588 Trazodone Antidepressant Human Plasma EDTA LC/MS/MS API 3000 10.0 3000
589 Trifluoperazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 8.00
590 Trimetazidine Antianginal Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 202
591 Trimethyl Phloroglucinol Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2500
592 Trospium Urinary Antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
593 Trospium (Sensitive) Urinary Antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.02 10.0
Page 62 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
594 Ulipristal Acetate Contraceptive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 160
595Valacyclovir +
AcyclovirAntiviral Human Plasma K3EDTA LC/MS/MS API 4000
5.00
50.0
1000
10000
596Valacyclovir +
AcyclovirAntiviral Human Plasma K3EDTA LC/MS/MS API 4000
5.00
50.0
1000
10000
597Valganciclovir +
Ganciclovirantiviral Human Plasma K3EDTA LC/MS/MS Premier XE
2.00
20.0
1000
10000
598 Valproic acid Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 400 40000
599 Valproic Acid Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 1000 150000
600 Valproic acid Anticonvulsant Human Plasma K2EDTA LC/MS/MS API 4000 1000 100000
601 Valproic Acid Anticonvulsant Human Plasma EDTA LC/MS/MS API 2000 1000 100000
602 Valsartan Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 5.00 5000
603 Valsartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 20.0 12000
604Valsartan +
Hydrochlorothiazide
Angiotension II Receptor
Antagonist
Diuretic
Human Plasma K3EDTA LC/MS/MS API 400040.0.
1.00
12000
300
605 Venetoclax Chronic lymphocytic leukemia Human Plasma K3EDTA LC/MS/MS API 5500 10.0 3000
606Venlafaxine +
O - Desmethyl Venlafaxine Antidepressant Human Plasma EDTA LC/MS/MS API 4000
2.00
3.00
500
750
Page 63 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
607Venlafexine (Sensitive) +
O - Desmethyl VenlafaxineAntidepressant Human Plasma K3EDTA LC/MS/MS API 4000
0.25
0.50
100
200
608Verapamil +
NorverapamilAntihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040
2.00
2.00
500
500
609 Vertaric acidAntihypertensive and
AntioxidantHuman Plasma K3EDTA LC/MS/MS API 4000 100.00 20000
610 Vildagliptin Anti diabetic Human Plasma K3EDTA LC/MS/MS API2000 2.00 800
611Vidagliptin +
MetforminAntidiabetic Human Plasma K3EDTA LC/MS/MS API 4000
2.00
10.0
800
4000
612 Vilazodone Antidepressant Human Plasma K3EDTA LC/MS/MS API2000 0.30 60
613 Voriconazole(Sensitive) Antifungal Human Plasma EDTA LC/MS/MS API 3000 30.00 9000
614 Voriconazole (Sensitive) Antifungal Human Plasma K3EDTA LC/MS/MS API 3000 25.00 5000
615 Voriconazole Antifungal Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
616 Vortioxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.05 20.0
617 Zidovudine Antiviral Human Plasma EDTA HPLC HPLC-UV 75.00 6000
618 Zidovudine (Sensitive) Antiviral Human Plasma Na Heparin HPLC HPLC-UV 20.00 4000
619 Zinc (Zinc Acetate)Inhibit the absorption of copper
in Wilson's diseaseHuman Plasma K3EDTA ICP OES Optima 8000 300 25000
Page 64 of 65 For more information email: [email protected]
Veeda Clinical Research Pvt. Ltd.Bioanalytical Method Library
Sr.
No. Drug Name Theraputic Class Matrix
Anti-
Coagulant Method Equipment
LLOQ
(ng/mL)
ULOQ
(ng/mL)
Validated Method List (Generics)
620 Zolpidem Insomnia Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 300
621 Zonisamide Antiepileptic Human Serum NA LC/MS/MS API 3200 10.0 3000
622
Zonisamide+
Topiramate +
Oxcarbazepine+
Phenytoin
Antiepileptic Human Plasma K2EDTA LC/MS/MS Premier XE
300
100
10.0
60.0
6000
20000
2000
12000
623 Zopiclone Hypnotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200
Validated Methods (Generics)Method Library -
NCE
PD /
Immunogenicity
Recently Validated
(Generics)
Recently
Validated (NCE)
Premium
Methods
(Generics)
Under
Development
/ Validation
623 60 16 4 1 50 23
Total
Methods754
Page 65 of 65 For more information email: [email protected]